Deciphering a GPCR-lncrna-miRNA nexus: Identification of an aberrant therapeutic target in ovarian cancer.

MLA

Ha, Ji Hee, et al. “Deciphering a GPCR-Lncrna-MiRNA Nexus: Identification of an Aberrant Therapeutic Target in Ovarian Cancer.” Cancer Letters, vol. 591, June 2024, p. 216891. EBSCOhost, https://doi.org/10.1016/j.canlet.2024.216891.

APA

Ha, J. H., Radhakrishnan, R., Nadhan, R., Gomathinayagam, R., Jayaraman, M., Yan, M., Kashyap, S., Fung, K.-M., Xu, C., Bhattacharya, R., Mukherjee, P., Isidoro, C., Song, Y. S., & Dhanasekaran, D. N. (2024). Deciphering a GPCR-lncrna-miRNA nexus: Identification of an aberrant therapeutic target in ovarian cancer. Cancer Letters, 591, 216891. https://doi.org/10.1016/j.canlet.2024.216891

Chicago

Ha, Ji Hee, Rangasudhagar Radhakrishnan, Revathy Nadhan, Rohini Gomathinayagam, Muralidharan Jayaraman, Mingda Yan, Srishti Kashyap, et al. 2024. “Deciphering a GPCR-Lncrna-MiRNA Nexus: Identification of an Aberrant Therapeutic Target in Ovarian Cancer.” Cancer Letters 591 (June): 216891. doi:10.1016/j.canlet.2024.216891.